These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27456991)

  • 1. Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis.
    Xiong H; Wu M; Yi H; Wang X; Wang Q; Nadirshina S; Zhou X; Liu X
    Sci Rep; 2016 Jul; 6():30356. PubMed ID: 27456991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.
    Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts.
    Płoski R; Brand OJ; Jurecka-Lubieniecka B; Franaszczyk M; Kula D; Krajewski P; Karamat MA; Simmonds MJ; Franklyn JA; Gough SC; Jarząb B; Bednarczuk T
    PLoS One; 2010 Nov; 5(11):e15512. PubMed ID: 21124799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between polymorphisms in the TSHR gene and Graves' orbitopathy.
    Jurecka-Lubieniecka B; Ploski R; Kula D; Szymanski K; Bednarczuk T; Ambroziak U; Hasse-Lazar K; Hyla-Klekot L; Tukiendorf A; Kolosza Z; Jarzab B
    PLoS One; 2014; 9(7):e102653. PubMed ID: 25061884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.
    Brand OJ; Barrett JC; Simmonds MJ; Newby PR; McCabe CJ; Bruce CK; Kysela B; Carr-Smith JD; Brix T; Hunt PJ; Wiersinga WM; Hegedüs L; Connell J; Wass JA; Franklyn JA; Weetman AP; Heward JM; Gough SC
    Hum Mol Genet; 2009 May; 18(9):1704-13. PubMed ID: 19244275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis.
    Wong KH; Rong SS; Chong KK; Young AL; Pang CP; Chen LJ
    Sci Rep; 2015 Nov; 5():16672. PubMed ID: 26578206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population.
    Liu L; Wu HQ; Wang Q; Zhu YF; Zhang W; Guan LJ; Zhang JA
    Endocr J; 2012; 59(8):717-23. PubMed ID: 22673349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in Taiwan.
    Liao WL; Wan L; Wang TY; Chen CC; Tse SS; Lu CH; Tsai FJ
    BMC Ophthalmol; 2014 Feb; 14():15. PubMed ID: 24517461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between
    Qian W; Xu K; Jia W; Lan L; Zheng X; Yang X; Cui D
    J Biomed Res; 2016 Nov; 30(6):466-475. PubMed ID: 27231040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy.
    Syed AA; Simmonds MJ; Brand OJ; Franklyn JA; Gough SC; Heward JM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):663-7. PubMed ID: 17608818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of chosen polymorphisms rs2476601 a/G - PTPN22, rs1990760 C/T - IFIH1, rs179247 a/G - TSHR in pathogenesis of autoimmune thyroid diseases in children.
    Rydzewska M; Góralczyk A; Gościk J; Wawrusiewicz-Kurylonek N; Bossowska A; Krętowski A; Bossowski A
    Autoimmunity; 2018 Jun; 51(4):183-190. PubMed ID: 29973096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Davies TF
    Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of
    Yaylacıoğlu Tuncay F; Serbest Ceylanoğlu K; Güntekin Ergün S; Ergün G; Konuk O
    Turk J Ophthalmol; 2024 Apr; 54(2):69-75. PubMed ID: 38645270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms at the PRR3, ABCF1, and GNL1 genes in the HLA class I region are associated with Graves' ophthalmopathy in a gender-dependent manner.
    Liu YH; Chen YJ; Wu HH; Wang TY; Tsai FJ
    Ophthalmology; 2014 Oct; 121(10):2033-9. PubMed ID: 24908204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
    J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.